Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin-XVIIIb (MYO18B) is an unconventional myosin and member of the myosin-18 family, highly expressed in striated muscle and involved in organizing the sarcomere—the fundamental contractile unit of muscle[1][2][3]. Unlike conventional myosins, it lacks classic ATP-dependent motor function, instead acting as a structural “glue” for actin and myosin bundles, facilitating actomyosin alignment and proper muscle development[1]. MYO18B also plays a mechanosensory role via the CaMKK2-AMPK-VASP pathway, is found broadly at low levels in various tissues, and can localize to the nucleus to regulate muscle-specific gene expression[1][2][3]. Mutations in MYO18B are associated with several muscle diseases and congenital anomalies, as well as loss of expression or mutation in certain cancers such as lung cancer[1][2][3]. No clinically approved drugs are known to directly target MYO18B.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin-XVIIIb (MYO18B).